About Syapse
Syapse is a company based in San Francisco (United States) founded in 2008 by Tony Loeser was acquired by N-Power Medicine in January 2025.. Syapse has raised $221.1 million across 8 funding rounds from investors including Medidata, Intermountain Healthcare and General Electric. The company has 209 employees as of December 31, 2022. Syapse operates in a competitive market with competitors including BostonGene, VieCure, Melatech, Myka Labs and Kuveda, among others.
- Headquarter San Francisco, United States
- Employees 209 as on 31 Dec, 2022
- Founders Tony Loeser
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Syapse, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$221.1 M (USD)
in 8 rounds
-
Latest Funding Round
$35 M (USD), Series E
Jul 07, 2022
-
Investors
Medidata
& 15 more
-
Employee Count
209
as on Dec 31, 2022
-
Acquired by
N-Power Medicine
(Jan 13, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Syapse
Syapse has successfully raised a total of $221.1M across 8 strategic funding rounds. The most recent funding activity was a Series E round of $35 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series E — $35.0M
-
First Round
First Round
(22 Jan 2013)
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2022 | Amount | Series E - Syapse | Valuation | Innovatus Capital Partners | |
| Feb, 2021 | Amount | Series E - Syapse | Valuation | Ally Bridge Group | |
| May, 2020 | Amount | Series E - Syapse | Valuation | Revelation Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Syapse
Syapse has secured backing from 16 investors, including venture fund and institutional investors. Prominent investors backing the company include Medidata, Intermountain Healthcare and General Electric. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified debt funding is provided for growth capital opportunities.
|
Founded Year | Domain | Location | |
|
Private equity and hedge fund investments in healthcare are managed.
|
Founded Year | Domain | Location | |
|
Corporate-backed venture capital is focused on the life science sector.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Syapse
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Syapse
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Syapse Comparisons
Competitors of Syapse
Syapse operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BostonGene, VieCure, Melatech, Myka Labs and Kuveda, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of cloud-based information and analytics platform to treat cancer
|
|
| domain | founded_year | HQ Location |
Oncology treatment plans are generated via an AI-based platform.
|
|
| domain | founded_year | HQ Location |
AI-based patient treatment management tool for providers
|
|
| domain | founded_year | HQ Location |
AI-based integrated solutions for interventional oncology procedures are provided.
|
|
| domain | founded_year | HQ Location |
SaaS tools for analyzing cancer patients' molecular profiles are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Syapse
Frequently Asked Questions about Syapse
When was Syapse founded?
Syapse was founded in 2008 and raised its 1st funding round 5 years after it was founded.
Where is Syapse located?
Syapse is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of Syapse?
Ken Tarkoff is the current CEO of Syapse.
Is Syapse a funded company?
Syapse is a funded company, having raised a total of $221.1M across 8 funding rounds to date. The company's 1st funding round was a Series E of $30M, raised on Jan 22, 2013.
How many employees does Syapse have?
As of Dec 31, 2022, the latest employee count at Syapse is 209.
What does Syapse do?
Syapse was founded in 2008 in San Francisco, United States, within the healthcare technology sector. A platform is provided by the company to enable molecular profiling and analysis of complex genomic data from cancer patients. Operations focus on precision medicine solutions that support clinical decision-making. Services are extended to healthcare providers and researchers across the United States, emphasizing data-driven oncology approaches.
Who are the top competitors of Syapse?
Syapse's top competitors include BostonGene, VieCure and Melatech.
Who are Syapse's investors?
Syapse has 16 investors. Key investors include Medidata, Intermountain Healthcare, General Electric, Social Capital, and Revelation Partners.